Prostacyclin--powerful, yes: but is it useful?
作者信息
Mitchell J R
出版信息
Br Med J (Clin Res Ed). 1983 Dec 17;287(6408):1824-6. doi: 10.1136/bmj.287.6408.1824.
Abstract
摘要
相似文献
1
Prostacyclin--powerful, yes: but is it useful?前列环素——效力强大，没错：但它有用吗？
Br Med J (Clin Res Ed). 1983 Dec 17;287(6408):1824-6. doi: 10.1136/bmj.287.6408.1824.
2
Prostacyclin in vascular pathology--therapeutic possibilities.血管病理学中的前列环素——治疗可能性
Ann Clin Res. 1984;16(5-6):253-61.
3
Clinical potential of prostacyclin.前列环素的临床潜力。
Adv Prostaglandin Thromboxane Leukot Res. 1983;11:449-56.
4
Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation.体外循环期间使用稳定前列环素类似物的抗栓管理。
Contrib Nephrol. 1991;93:205-9. doi: 10.1159/000420220.
5
Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.前列环素与前列腺素E1：分子机制及治疗用途
Prog Hemost Thromb. 1991;10:307-37.
6
Clinical pharmacology and potential of prostacyclin.前列环素的临床药理学及潜力
Br Med Bull. 1983 Jul;39(3):281-4. doi: 10.1093/oxfordjournals.bmb.a071834.
7
Effect of iloprost on in vivo and in vitro platelet function in patients with peripheral vascular disease (PVD).伊洛前列素对外周血管疾病（PVD）患者体内和体外血小板功能的影响。
Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:450-4.
8
Iloprost in peripheral vascular disease--platelet function and clinical outcome.
Prog Clin Biol Res. 1987;242:463-8.
9
10
Clinical benefit and prolongation of platelet half-life induced by CG 4203, a stable PGI2-analogue.稳定的前列环素类似物CG 4203诱导的临床益处及血小板半衰期延长
Prog Clin Biol Res. 1987;242:469-77.
引用本文的文献
1
Current issues in thrombosis prevention with antiplatelet drugs.抗血小板药物预防血栓形成的当前问题。
Drugs. 1986 Jun;31(6):517-49. doi: 10.2165/00003495-198631060-00004.
本文引用的文献
1
[The chemistry of prostaglandin].[前列腺素的化学]
Nord Med. 1949 Sep 9;42(36):1465.
2
Clinical pharmacology and potential of prostacyclin.前列环素的临床药理学及潜力
Br Med Bull. 1983 Jul;39(3):281-4. doi: 10.1093/oxfordjournals.bmb.a071834.
3
Treatment of ischaemic stroke with prostacyclin.
Stroke. 1983 Mar-Apr;14(2):197-202. doi: 10.1161/01.str.14.2.197.
4
Pharmacological interactions between prostacyclin and thromboxanes.前列环素与血栓素之间的药理相互作用。
Br Med Bull. 1983 Jul;39(3):232-8. doi: 10.1093/oxfordjournals.bmb.a071825.
5
Clinical aspects of the arachidonic acid--thromboxane pathway.
Br Med Bull. 1983 Jul;39(3):289-95. doi: 10.1093/oxfordjournals.bmb.a071836.
6
Epoprostenol (prostacyclin) decreases platelet deposition on vascular prosthetic grafts.依前列醇（前列环素）可减少血小板在血管人工移植物上的沉积。
Lancet. 1983 Jun 4;1(8336):1275-6. doi: 10.1016/s0140-6736(83)92721-6.
7
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo.前列腺素E1对体内外血小板行为的影响。
Br Med J. 1967 May 20;2(5550):468-72. doi: 10.1136/bmj.2.5550.468.
8
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.抑制前列腺素合成作为阿司匹林类药物的作用机制。
Nat New Biol. 1971 Jun 23;231(25):232-5. doi: 10.1038/newbio231232a0.
9
Prostaglandin E 1 and human platelets.前列腺素E1与人体血小板
Lancet. 1969 Jul 12;2(7611):111. doi: 10.1016/s0140-6736(69)92428-3.
10
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.血栓素：一类从前列腺素内过氧化物衍生而来的新型生物活性化合物。
Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994-8. doi: 10.1073/pnas.72.8.2994.
Zotero 插件